je.st
news
Tag: gsk
Novartis buys remaining rights to GSK treatment in deal up to $1 billion
2015-08-21 09:12:45| Biotech - Topix.net
Swiss drugmaker Novartis said on Friday it had agreed to buy all remaining rights to Ofatumumab, which is being developed for relapsing remitting multiple sclerosis and other autoimmune indications, from Britain's GlaxoSmithKline. Basel-based Novartis will make an initial upfront payment of $300 million to GSK for the acquisition of the compound and a further $200 million payable following the start of a phase III study in MS by Novartis.
Tags: to
rights
treatment
deal
GSK hopes big clinical trial can breathe new life into lung drug
2015-08-13 20:06:52| Biotech - Topix.net
GlaxoSmithKline is banking on a major clinical trial to revive its flagging respiratory medicine business, with billions of dollars of sales riding on a positive result. Data from the so-called SUMMIT study, designed to show GSK's Breo can prolong lives of patients with chronic lung disease, are expected as early as next month, nine years after a similar study with GSK's older drug Advair failed by a whisker.
GSK temporarily shuts down N.C. site due to bacteria in cooling tower
2015-08-12 14:53:42| Biotech - Topix.net
The GlaxoSmithKline drug manufacturing facility in Zebulon has been temporarily shut down due to bacteria found in the cooling towers. Spokeswoman Jenni Brewer Ligday confirmed that the site was shut down Tuesday as a result of "routine testing found bacteria in the cooling towers."
GSK closes North Carolina plant after Legionnaires' bacteria found
2015-08-12 07:09:51| Biotech - Topix.net
Drugmaker GlaxoSmithKline closed its North Carolina factory on Tuesday after testing at a cooling tower found bacteria that causes deadly Legionnaire's disease, a company spokeswoman said. The Legionella bacteria was discovered during routine inspections at the site in Zebulon, N.C., GSK spokeswoman Jenni Brewer Ligday said.
Tags: found
north
carolina
plant
Exclusive: GSK Faces New Corruption Allegations, This Time In Romania
2015-07-30 18:07:04| Biotech - Topix.net
Drugmaker GlaxoSmithKline, which was fined a record 3 billion yuan for corruption in China last year and is examining possible staff misconduct elsewhere, faces new allegations of bribery in Romania. GSK confirmed it was looking into the latest claims of improper payments set out in a whistleblower's email sent to its top management on Monday.
Tags: time
exclusive
romania
faces
Sites : [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] next »